Evidence map›Paper›PMID 38715035›Full record

ArticleMalaria journal2024

A qualitative look at bed net access and use in Burkina Faso, Mozambique, Nigeria, and Rwanda following piloted distributions of dual-active ingredient insecticide-treated nets.

Jenny Shannon, Moubassira Kagone, Baltazar Candrinho, Sylvanus Otikwu, Chantal Ingabire, Adama Gansane, Samy Pooda, Fofana Aboubacar, Fatou Ouattara, Binete Savaio and 21 more

Abstract read
In one paragraph

Article in Malaria journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Comparative malaria impact of chlorfenapyr-α-cypermethrin netsCurrent research in parasitology & vector-borne diseases · 2026
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Jenny ShannonPATH, Seattle, WA, USA. jshannon@path.org.
Moubassira KagoneCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Baltazar CandrinhoNational Malaria Control Programme, Ministry of Health, Maputo, Mozambique.
Sylvanus OtikwuIbolda Health International, Abuja, Nigeria.
Chantal IngabireUniversity of Rwanda, Kigali, Rwanda.
Adama GansaneCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Samy PoodaCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Fofana AboubacarCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Fatou OuattaraCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Binete SavaioPATH, Maputo, Mozambique.
Celestino JoangueteTropical Health LLP, London, UK.
Lucio SixpenceTropical Health LLP, London, UK.
Hannah KoenkerTropical Health LLP, London, UK.
Perpetua UhomoibhiNational Malaria Elimination Programme, Federal Ministry of Health, Abuja, Nigeria.
Okefu Oyale OkokoNational Malaria Elimination Programme, Federal Ministry of Health, Abuja, Nigeria.
Onoja AliIbolda Health International, Abuja, Nigeria.
Dele BabarindeIbolda Health International, Abuja, Nigeria.
Janet OgundairoIbolda Health International, Abuja, Nigeria.
Ayorinde Samuel LemahIbolda Health International, Abuja, Nigeria.
Aimable MbituyumuremyiRwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Joseph H SingirankaboUniversity of Rwanda, Kigali, Rwanda.
Nami KawakyuPATH, Seattle, WA, USA.
Federica GuglielmoLiverpool School of Tropical Medicine, Liverpool, UK.
Christen FornadelIVCC, Liverpool, UK.
Kyra ArnettPATH, Seattle, WA, USA.
Joe WagmanPATH, Washington, DC, USA.
Christelle GoguePATH, Washington, DC, USA.
Kenzie TynuvPATH, Washington, DC, USA.
Peder DigrePATH, Seattle, WA, USA.
Julia MwesigwaPATH, Kampala, Uganda.
Molly RobertsonPATH, Washington, DC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUniversal coverage with insecticide-treated nets (ITNs) is important for malaria control and elimination. The emergence and intensification of insecticide resistance threatens progress made through the deployment of these interventions and has required the development of newer, more expensive ITN types. Understanding malaria prevention behaviour, including barriers and facilitators to net access and use, can support effective decision-making for the promotion and distribution of ITNs.

methodsIn-depth interviews and focus group discussions were conducted in 3 to 4 villages per district, in 13 districts across Burkina Faso, Mozambique, Nigeria and Rwanda from 2019 to 2022. Interviews were conducted in the local language, translated and transcribed in English, French or Portuguese. Transcripts were coded and analysed using Nvivo and ATLAS.ti.

resultsITNs were obtained from mass distribution campaigns, antenatal care and immunization visits, and purchased on the private market in some locations. While there were divergent perspectives in whether the number of distributed nets were adequate, participants consistently expressed concerns of bias, discrimination, and a lack of transparency with the distribution process. ITNs were frequently used alongside other malaria prevention methods. The primary motivation for use was malaria prevention. While some participants reported using nets nightly throughout the year, other participants reported seasonal use, both due to the perceived higher density of mosquitoes and discomfort of sleeping under a net in the increased heat. Other barriers to consistent net use included activities that take place away from the home, sleeping patterns and arrangements, and sensitivity to the insecticides on the nets.

conclusionsITNs remain an important malaria control intervention. To ensure adequate and increased net access, distribution campaigns should consider family structures, available sleeping spaces, and other bed sharing preferences when identifying the number of nets needed for distribution. In addition, campaigns should allow for multiple options for net distribution points and timing to accommodate households remote to health services. Continuous distribution channels and complimentary distribution through the private sector could help fill gaps in coverage. Solutions are needed for outdoor malaria transmission, including alternative designs for ITNs, and improving access to complementary personal protective measures.

Indexed as

Insecticide-Treated BednetsMalariaMosquito ControlAdultBurkina FasoFemaleFocus GroupsHumansMaleMiddle AgedMozambiqueNigeriaRwandaYoung AdultAccessCareHuman behaviorInsecticide-treated bed netsMalariaQualitativeUse

Identifiers

PMID38715035
PMCPMC11077758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.